Mesoblast Ltd (ASX:MSB)
Pharmaceuticals, Biotechnology & Life Sciences
share price: (EoD)
earnings per share:
dividends per share:
Mesoblast Ltd (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.
Mesoblast Ltd (ASX:MSB) share price
Mesoblast Ltd (ASX:MSB) share price news
ASX Growth Shares
Why the Mesoblast (ASX:MSB) share price is up 6%
The Mesoblast Limited (ASX:MSB) share price is up more than 6% after announcing that it has won an award.
September 15, 2020
Today's ASX news
Mesoblast’s (ASX:MSB) good COVID-19 news
Mesoblast Limited (ASX:MSB) shares dropped 3% on Friday after announcing news relating to COVID-19 patients.
September 5, 2020
ASX Growth Shares
Mesoblast (ASX:MSB) share price rockets higher
The Mesoblast Limited (ASX:MSB) share price has soared 38% higher after the biotech business announced positive US news.
August 14, 2020
ASX Growth Shares
Mesoblast (ASX:MSB) share price sinks 30% on FDA report
The Mesoblast Limited (ASX: MSB) share price has taken a dive today after the company’s quest to obtain FDA approval for its lead drug candidate hit a speed bump.
August 11, 2020
Today's ASX news
S&P/ASX 200 morning report – jump expected
The S&P/ASX 200 (ASX: XJO) and the broader Australian share market is expected to open higher on Monday morning, with the Sydney Futures Exchange pointing to a positive open of 82 points.
April 27, 2020
Today's ASX news
Mesoblast Capital Raising- Share Price Falls 10%
Shares in Mesoblast Limited (ASX:MSB) fell as much as 10% this morning after the company successfully completed a $75 million capital raising.
October 3, 2019
Today's ASX news
Why The Mesoblast Share Price Is Going Bonkers
Shares in Mesoblast Limited (ASX:MSB) have soared more than 30% in just over 24 hours following yesterday’s announcement of a strategic partnership with a German pharmaceutical business.
September 11, 2019
Today's ASX news
ASX 200 (XJO) To Open Higher, 3 ASX Shares To Watch
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 1.27% on Thursday.
August 30, 2019
Today's ASX news
Why The Mesoblast (ASX:MSB) Share Price Is Down
The Mesoblast Limited (ASX:MSB) share price is down around 2.5% after announcing its March 2019 update.
May 31, 2019
